ES2333244T3 - Usos antivirales de complejos de acido borinico. - Google Patents

Usos antivirales de complejos de acido borinico. Download PDF

Info

Publication number
ES2333244T3
ES2333244T3 ES05856817T ES05856817T ES2333244T3 ES 2333244 T3 ES2333244 T3 ES 2333244T3 ES 05856817 T ES05856817 T ES 05856817T ES 05856817 T ES05856817 T ES 05856817T ES 2333244 T3 ES2333244 T3 ES 2333244T3
Authority
ES
Spain
Prior art keywords
alkyl
compound
substituted
animal
prevention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES05856817T
Other languages
English (en)
Spanish (es)
Inventor
Carolyn Bellinger-Kawahara
Kirk R. Maples
Jacob J. Plattner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anacor Pharmaceuticals LLC
Original Assignee
Anacor Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anacor Pharmaceuticals LLC filed Critical Anacor Pharmaceuticals LLC
Application granted granted Critical
Publication of ES2333244T3 publication Critical patent/ES2333244T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/69—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES05856817T 2004-06-14 2005-06-14 Usos antivirales de complejos de acido borinico. Expired - Lifetime ES2333244T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57941904P 2004-06-14 2004-06-14
US579419P 2004-06-14

Publications (1)

Publication Number Publication Date
ES2333244T3 true ES2333244T3 (es) 2010-02-18

Family

ID=36623539

Family Applications (1)

Application Number Title Priority Date Filing Date
ES05856817T Expired - Lifetime ES2333244T3 (es) 2004-06-14 2005-06-14 Usos antivirales de complejos de acido borinico.

Country Status (12)

Country Link
US (1) US7393856B2 (enExample)
EP (1) EP1765360B1 (enExample)
JP (1) JP2008502694A (enExample)
AT (1) ATE447960T1 (enExample)
BR (1) BRPI0512049A (enExample)
CA (1) CA2570577A1 (enExample)
DE (1) DE602005017626D1 (enExample)
ES (1) ES2333244T3 (enExample)
MX (1) MXPA06014417A (enExample)
PT (1) PT1765360E (enExample)
TW (1) TW200612967A (enExample)
WO (1) WO2006085932A2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006332797A1 (en) * 2005-12-28 2007-07-12 Anacor Pharmaceuticals, Inc. Process for manufacturing picolinate borinic esters
BRPI0708051A2 (pt) 2006-02-16 2011-05-17 Anacor Pharmaceuticals Inc moléculas pequenas contendo boro como agentes antiflamatórios
JP5606913B2 (ja) * 2008-08-11 2014-10-15 独立行政法人科学技術振興機構 蛋白質架橋阻害剤
US8980544B2 (en) 2012-11-27 2015-03-17 The Penn State Research Foundation Boronic and borinic acid compounds as inhibitors of sulfenic acid-containing proteins
UY35287A (es) 2013-01-30 2014-08-29 Dow Agrosciences Llc Uso de benzoxaborolas como agentes antimicrobianos volátiles en carnes, plantas o partes de plantas.
US10070649B2 (en) 2013-01-30 2018-09-11 Agrofresh Inc. Volatile applications against pathogens
US11039617B2 (en) 2013-01-30 2021-06-22 Agrofresh Inc. Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness
US9585396B2 (en) 2013-01-30 2017-03-07 Agrofresh Inc. Volatile applications against pathogens
US8669207B1 (en) 2013-01-30 2014-03-11 Dow Agrosciences, Llc. Compounds and compositions
KR101756785B1 (ko) 2015-03-10 2017-07-12 한국화학연구원 4배위 유기 붕소 화합물의 제조방법
EP3426029B1 (en) 2016-03-07 2023-08-30 AgroFresh Inc. Synergistic methods of using benzoxaborole compounds and preservative gases as an antimicrobial for crops
EP3609504A4 (en) 2017-03-01 2021-03-03 Anacor Pharmaceuticals, Inc. NEW OXABOROLE ANALOGUES AND USES OF THE LATEST
TWI883391B (zh) * 2020-02-18 2025-05-11 美商基利科學股份有限公司 抗病毒化合物
US20230340530A1 (en) 2020-08-31 2023-10-26 Pfizer Inc. Methods of Protecting RNA

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5788800A (en) 1999-07-07 2001-01-22 Du Pont Pharmaceuticals Company Peptide boronic acid inhibitors of hepatitis c virus protease
EP1581500A4 (en) 2002-12-18 2008-03-05 Anacor Pharmaceuticals Inc ANTIBIOTICS CONTAINING BORINIC ACID COMPLEXES AND METHODS OF USE

Also Published As

Publication number Publication date
TW200612967A (en) 2006-05-01
EP1765360A2 (en) 2007-03-28
DE602005017626D1 (de) 2009-12-24
CA2570577A1 (en) 2006-08-17
EP1765360B1 (en) 2009-11-11
JP2008502694A (ja) 2008-01-31
BRPI0512049A (pt) 2008-02-06
WO2006085932A2 (en) 2006-08-17
US7393856B2 (en) 2008-07-01
WO2006085932A3 (en) 2006-10-05
ATE447960T1 (de) 2009-11-15
PT1765360E (pt) 2009-12-24
HK1102702A1 (en) 2007-11-30
MXPA06014417A (es) 2007-03-08
US20060019927A1 (en) 2006-01-26

Similar Documents

Publication Publication Date Title
ES2333244T3 (es) Usos antivirales de complejos de acido borinico.
ES3035833T3 (en) Use of substituted aminopropionate compounds in treatment of sars-cov-2 infection
ES2710662T3 (es) Compuestos de acilguanidina con actividad antiviral
AU2005254095B2 (en) Treatment or prevention of skin conditions or tissue conditions in animals using boryloxypyridylmethanones
ES2724275T3 (es) 1,2,4-triazoles como moduladores del transporte nuclear y usos de los mismos
AU2018215203B2 (en) Nucleotide hemi-sulfate salt for the treatment of hepatitis C virus
US8969373B2 (en) HCV protease inhibitors
CN111511729A (zh) Tlr7/8拮抗剂及其用途
ES2605942T3 (es) Uso de un derivado de pirazol en el tratamiento de exacerbaciones agudas de enfermedad pulmonar obstructiva crónica
ES2289004T3 (es) Nuevos compuestos.
CA2363274A1 (en) Fused-ring compounds and use thereof as drugs for hepatitis c
IL217228A (en) Compounds of Type 2'-Deoxy-2'-Fluoro-2'-c-Methyluridine Nucleoside Phosphoramide Compounds
DK169657B1 (da) Anvendelse af visse uracilnucleosider til fremstilling af et lægemiddel mod adenovirusinfektioner samt oftalmiske præparater indeholdende sådanne uracilnucleosider
KR20180086258A (ko) 술폰아마이드 유도체 및 그 제조방법과 응용
CA3227602A1 (en) Inhibitors for coronaviruses
ES2597803T3 (es) Derivados de naftiridinona y su uso en el tratamiento, mejora o prevención de una enfermedad viral
CN115304590A (zh) 2h-苯并三氮唑衍生物及其制备方法及含有它们的药物组合物
HU227677B1 (en) Antiviral combinations of lamivudine and adefovir
HK1102702B (en) Anti-viral uses of borinic acid complexes
US20160137685A1 (en) Nucleoside phosphoramidates and phosphoramidites
WO2022183493A1 (zh) 一种多酚类化合物的应用
EP1169041A2 (en) Use of carbamic acid derivatives for the treatment of viral infections
RU2726456C1 (ru) Ингибитор вируса гепатита В (ВГВ)
CN100540002C (zh) 盐酸青藤碱在制备治疗胶质瘤药物方面的用途
US20240024294A1 (en) Compositions and methods for the treatment or prevention of preterm labor